A Study to Investigate the Genetic Variation of Dopamine Pathway in Patients With Chronic Pain
CompletedNot applicableNCT02989792
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients having completed former trials T1001-01 or T1001-02 will undergo one blood sampling for genotyping purposes. In addition they will compete the personality questionnaires they had completed in the former trial.
Study details
- Official title
- A Study to Investigate the Genetic Variation of Dopamine Pathway Associated With the Observed Effects of a New Treatment in Former Studies in Patients With Chronic Pain
- Conditions
- Interventions
- Genetic: Blood sampling for genotyping
- Other: Personality Questionnaires completion
- Sponsor
- Tools4Patient
- Start date
- 2017-02-08
- Primary completion
- 2017-10-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium, France
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * have completed T1001-01 or T1001-02 study (Visit 5 completed) * are men or women of at least 18 years of age * have given written informed consent approved by the relevant Ethics Committee governing the study sites Exclusion Criteria: * have any close relationship with the Investigators or the Sponsor * are under legal protection, according to the national law
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02989792